A US judge on Friday approved German chemical giant Bayer’s $7.25 billion settlement of lawsuits claiming its Roundup weedkiller causes cancer, but the payments to victims will average as little as $10,000.
Judge Timothy Boyer in Missouri ruled that the agreement was “fair, reasonable, and adequate.” The decision could help Bayer end years of costly legal battles over Roundup, which the company acquired when it bought US weedkiller producer Monsanto in 2018.
“The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” Bayer CEO Bill Anderson said.
The Payouts
The agreement covers tens of thousands of people who say they developed non-Hodgkin lymphoma after using Roundup, as well as people who may be diagnosed in the future after previous exposure.

Bayer will pay up to $7.25 billion into a special fund over the next 21 years. Individual payments are expected to average between $10,000 and $165,000. The amount will depend on factors including the patient’s age, the severity of the illness, and how long they were exposed to Roundup.
Some lawyers representing cancer patients have criticized the payments as too low. But the judge rejected their objections, saying that further delays could leave seriously ill patients waiting years for compensation.
Christopher Seeger, a lawyer representing cancer patients, welcomed the decision. “Today’s final approval order delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice,” he said.
The Supreme Court Factor
The settlement follows a major victory for Bayer at the US Supreme Court in June. The court ruled that Bayer could not be sued under state laws for failing to put cancer warnings on Roundup packaging. The judges argued that federal rules did not require such warnings and that individual states could not impose additional labeling requirements.
The decision made it much harder for cancer patients to win lawsuits against Bayer. In October, a Missouri jury also ruled in Bayer’s favor in a separate Roundup cancer case. However, around 200 cases are still being fought in federal courts outside the new settlement.
The Cost of Roundup
Monsanto introduced Roundup in 1974. Its main ingredient, glyphosate, became one of the world’s most widely used weedkillers. Bayer inherited the legal problems surrounding Roundup when it bought Monsanto for $63 billion in 2018.
Since then, around 200,000 claims have been made against Bayer by people who believe the weedkiller caused their cancer. The company already agreed to a $10.9 billion settlement in 2020. Some lawsuits have resulted in huge payouts, including a $2.1 billion award to plaintiffs in Georgia.
Bayer has already set aside $16 billion for Roundup-related legal costs. Its shares have fallen by 46 percent since the Monsanto takeover.
The Science
Scientists and regulators disagree about whether glyphosate causes cancer. In 2015, the World Health Organization’s cancer research agency classified the chemical as “probably carcinogenic” to humans. However, the US Environmental Protection Agency says glyphosate is unlikely to cause cancer when used as directed.
Bayer has repeatedly denied that Roundup causes cancer, pointing to scientific studies and regulatory approvals. The debate intensified last year when a major scientific study that had supported Roundup’s safety for decades was withdrawn. The journal that published it cited serious problems, including missing cancer research and previously undisclosed involvement by Monsanto employees.
The Bottom Line
A US judge has approved Bayer’s $7.25 billion settlement of lawsuits claiming Roundup causes cancer. Victims will receive between $10,000 and $165,000 on average. Some lawyers say the payments are too low. The settlement follows a Supreme Court ruling that made it harder to sue Bayer for failing to warn about cancer risks. About 200 cases remain outside the settlement.
My Opinion
Bayer bought Monsanto for $63 billion. It has set aside $16 billion for legal costs. And now it is paying $7.25 billion to the people whose lives it may have ruined.
The average payout for a cancer victim will be between $10,000 and $165,000. Think about what that means. A person develops non-Hodgkin lymphoma after years of using Roundup on their lawn. They endure chemotherapy, radiation, the fear, the pain, the uncertainty. They lose time with their families. They lose their health. They may lose their lives. And Bayer, the company that made the product, will write them a check for what amounts to a used car.
The lawyers who criticized the settlement are right. It is too low. But the judge approved it anyway, saying that delays could leave seriously ill patients waiting years for compensation. That is the cruel logic of the American legal system. Victims are forced to choose between a paltry settlement now and a potentially larger one years down the road, when they may already be dead.
And here is the part that should make you angry. The Supreme Court made this possible. In June, the court ruled that Bayer could not be sued under state laws for failing to warn about cancer risks. The decision stripped away one of the most powerful tools that victims had.





